Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

AGM Statement

16 Jun 2009 07:00

Embargoed Release: 07:00hrs Tuesday 16 June 2009

SOPHEON PLC AGM Statement

At the Annual General Meeting of Sopheon plc to be held later today, the chairman of the board will give shareholders an update and review of the business. This will include the following statement:

"Sopheon delivered a landmark performance in 2008. We reported revenues of £ 9.3m, a year-over-year increase of 47%. We also showed good improvement in profitability. Since the start of 2009, we have closed a total of 15 new and extension license orders. The total licensee base now stands at 163 and recurring revenues from maintenance, hosting and rental licenses now stand at £ 4 million compared to £2.9 million a year ago. Revenue visibility for the full year from contracted business and recurring revenue streams, now stands at £ 6.2 million. We had expected to report a higher figure to shareholders at this point in time, however, as noted in our Interim Management Statement of 7 May, our performance in current market conditions remains unpredictable. A number of opportunities that we had expected to close in the second quarter are now unlikely to conclude until the third or fourth quarters of the year. Several of these prospects have attributed the delays to more stringent approval processes imposed due to the current market uncertainty.

The majority of the affected prospects remain in active sales cycles, and a number of them are beginning to indicate early signs of improvement in conditions. Accordingly, we continue to expect to close these opportunities in the second half of the year, in addition to new business originally identified for the third and fourth quarters. This will be a major challenge but one we will embrace with vigour. The impact of the economy aside, such delays are not a new experience for Sopheon. We have consistently noted our business dependency on a small number of relatively large deals, any of which can materially impact the revenue recorded in a particular period. While we do anticipate closing further business in June, a possible effect of the ongoing delays is that revenues in the first half of 2009 may be lower than those recorded in the comparable period last year. With higher costs due to higher staff levels (particularly in product development) and the impact of the weakness of Sterling, this is expected to result in an EBITDA loss for the first half of the year. In our announcement of 7 May we noted that while we had expanded investment in product development, we had taken action to reduce and reorganize certain operational groups. The financial benefit of this adjustment will feed through into the second half the year. However, as a prudent measure in these unpredictable times, we are evaluating further cost adjustments, as well as negotiating improved cash facilities.

As we face the current challenges, we are fortified by our recent achievements. Over the last two years we have evolved Sopheon from a single product company to one with a product family of three. This has been accomplished through a combination of strategic investment, partnership activity and an unremitting focus on product development. Our first milestone in this expansion in scope was in 2007 with the acquisition of Alignent Software, bringing its Vision Strategist roadmapping solution into our product set. This was followed last year with the pivotal release of version 7.0 of our core Accolade platform. Most recently, we announced the launch of Idea Lab, our new idea development software, which has expanded the capacity of our solution set to strengthen the front-end of the product innovation process. With this launch, Sopheon now offers the first software suite in the industry to provide all-in-one support that encompasses innovation strategy, ideation and execution. We remain convinced that this represents a highly differentiated value proposition, and are encouraged by strong interest from the market and influential, positive affirmation from the business analyst community."

-Ends-

For further information contact:

Barry Mence, Chairman Sopheon plc + 44 (0) 1483 685 735

Arif Karimjee, CFO Vikki Krause Hansard Communications + 44 (0) 207 245 1100 + 44 (0) 7515 922906 Claire Verhagen Citigate First Financial + 31 (0) 205 754 010 Sarah Jacobs Seymour Pierce + 44 (0) 207 107 8000 About Sopheon

Sopheon is an international provider of software and services that help organisations improve the business impact of product innovation. Sopheon's solutions automate and govern the innovation process, enabling companies to increase revenue and profits from new products. Sopheon's solutions are used by industry leaders throughout the world, including BASF, Cadbury Schweppes, Corning, Electrolux, General Motors, Honeywell, Motorola and SAB Miller. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com.

vendor
Date   Source Headline
24th Jul 20199:05 amRNSSecond Price Monitoring Extn
24th Jul 20199:00 amRNSPrice Monitoring Extension
24th Jul 20197:00 amRNSTrading Update
13th Jun 20191:06 pmRNSResult of AGM
13th Jun 20197:00 amRNSAccolade 12.3
13th Jun 20197:00 amRNSAGM Statement
11th Jun 20191:32 pmRNSIssue of Equity
15th May 20197:00 amRNSSopheon Expands Customer Foothold in Asia
13th May 20199:14 amRNSIssue of Equity
28th Mar 20197:00 amRNSSopheon and National Foods Limited Partnership
21st Mar 20197:00 amRNSFinal Results
5th Feb 20197:00 amRNSIssue of Equity
29th Jan 20197:00 amRNSTrading Update
24th Jan 20194:41 pmRNSSecond Price Monitoring Extn
24th Jan 20194:35 pmRNSPrice Monitoring Extension
17th Jan 20197:00 amRNSAccolade Release 12.2
11th Jan 20197:00 amRNSTrading Update
8th Jan 20197:00 amRNSSopheon Partners with The Hershey Company
18th Dec 20182:53 pmRNSIssue of Equity
16th Nov 201812:54 pmRNSIssue of Equity
31st Oct 20185:18 pmRNSIssue of Equity
23rd Oct 20187:00 amRNSSopheon Awarded The Nature's Bounty Co. Business
8th Oct 20189:05 amRNSSecond Price Monitoring Extn
8th Oct 20189:00 amRNSPrice Monitoring Extension
8th Oct 20187:00 amRNSTrading Update
10th Sep 20187:00 amRNSDoosan Bobcat Awards Sopheon Innovation Contract
7th Sep 20185:48 pmRNSIssue of Equity
29th Aug 20183:54 pmRNSIssue of Equity & Holdings in Company
28th Aug 20187:00 amRNSAccolade Enterprise Innovation Management
23rd Aug 20187:00 amRNSHalf Yearly Report
19th Jul 201811:05 amRNSSecond Price Monitoring Extn
19th Jul 201811:00 amRNSPrice Monitoring Extension
19th Jul 20187:00 amRNSTrading Update
5th Jul 20189:40 amRNSGrant of Options / PDMR Dealing
3rd Jul 20189:24 amRNSIssue of Equity
13th Jun 20182:37 pmRNSIssue of Equity
7th Jun 201812:09 pmRNSResult of AGM
7th Jun 20187:00 amRNSAGM Statement
31st May 20182:56 pmRNSIssue of Equity
17th May 20188:01 amRNSResult of Secondary Placing
16th May 20183:05 pmRNSProposed Secondary Placing
15th May 20187:00 amRNSIssue of Equity
27th Apr 20183:59 pmRNSIssue of Equity
29th Mar 20187:00 amRNSAccolade Release 12.0
23rd Mar 20183:56 pmRNSIssue of Equity
23rd Mar 20187:00 amRNSIssue of Equity
22nd Mar 20187:00 amRNSFinal Results
20th Feb 20187:00 amRNSSopheon named in Annual Reader's Choice List
12th Feb 20189:24 amRNSGrant of Options / PDMR dealing
5th Feb 20183:35 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.